Pang‐Hsien Tu

6.2k total citations · 2 hit papers
48 papers, 5.0k citations indexed

About

Pang‐Hsien Tu is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pang‐Hsien Tu has authored 48 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 21 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pang‐Hsien Tu's work include Amyotrophic Lateral Sclerosis Research (13 papers), Alzheimer's disease research and treatments (9 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Pang‐Hsien Tu is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (13 papers), Alzheimer's disease research and treatments (9 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Pang‐Hsien Tu collaborates with scholars based in Taiwan, United States and Japan. Pang‐Hsien Tu's co-authors include John Q. Trojanowski, Takeshi Iwatsubo, Shigeo Nakajo, Kazuyasu Nakaya, Masaya Baba, Tatsuo Tomita, Virginia M.‐Y. Lee, Yijuang Chern, Taisuke Tomita and Susan Leight and has published in prestigious journals such as Journal of the American Chemical Society, Physical Review Letters and Nature Communications.

In The Last Decade

Pang‐Hsien Tu

47 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

1998 1.4k citations Shigeo Nakajo, Pang‐Hsien Tu et al. profile →
Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

1998 558 citations Pang‐Hsien Tu, James E. Galvin et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pang‐Hsien Tu Taiwan	33	3.1k	1.7k	1.4k	1.3k	847	48	5.0k
Koichi Okamoto Japan	41	2.3k 0.7×	2.1k 1.2×	1.5k 1.1×	1.0k 0.8×	879 1.0×	216	5.5k
Paul Lingor Germany	43	1.7k 0.5×	2.5k 1.4×	963 0.7×	1.8k 1.4×	747 0.9×	154	5.7k
Thomas Brännström Sweden	41	2.6k 0.8×	2.1k 1.2×	810 0.6×	1.1k 0.9×	863 1.0×	107	5.6k
Jasna Križ Canada	40	1.8k 0.6×	1.6k 1.0×	631 0.5×	915 0.7×	2.3k 2.7×	104	5.5k
Jennifer Bruce United States	27	4.2k 1.4×	2.8k 1.7×	1.9k 1.4×	892 0.7×	1.1k 1.3×	45	7.3k
Jean-Pierre Julien Canada	17	1.5k 0.5×	1.3k 0.7×	953 0.7×	663 0.5×	1.4k 1.7×	20	4.6k
Manabu Doyu Japan	42	2.5k 0.8×	4.1k 2.4×	804 0.6×	3.4k 2.7×	589 0.7×	107	6.8k
Julie D. Atkin Australia	37	2.0k 0.7×	1.6k 1.0×	600 0.4×	517 0.4×	508 0.6×	79	4.0k
Wolfgang Roggendorf Germany	38	1.2k 0.4×	1.5k 0.9×	709 0.5×	702 0.6×	685 0.8×	109	4.7k
Thomas R. Caulfield United States	32	1.5k 0.5×	2.6k 1.5×	891 0.6×	560 0.4×	377 0.4×	102	4.9k

Countries citing papers authored by Pang‐Hsien Tu

Since Specialization

Citations

This map shows the geographic impact of Pang‐Hsien Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pang‐Hsien Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pang‐Hsien Tu more than expected).

Fields of papers citing papers by Pang‐Hsien Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pang‐Hsien Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pang‐Hsien Tu. The network helps show where Pang‐Hsien Tu may publish in the future.

Co-authorship network of co-authors of Pang‐Hsien Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Pang‐Hsien Tu. A scholar is included among the top collaborators of Pang‐Hsien Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pang‐Hsien Tu. Pang‐Hsien Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Chen, et al.. (2017). An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice. EMBO Molecular Medicine. 9(5). 703–715. 52 indexed citations

Chen, Guang‐Chao, et al.. (2014). Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy. 11(4). 685–700. 136 indexed citations

Lin, Yu‐Ching, Cheng‐Hsin Liu, Yating Wang, et al.. (2014). USP11 regulates PML stability to control Notch-induced malignancy in brain tumours. Nature Communications. 5(1). 16167–16167. 87 indexed citations

Hsiao, Han‐Yun, Yu‐Chen Chen, Huimei Chen, Pang‐Hsien Tu, & Yijuang Chern. (2013). A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease. Human Molecular Genetics. 22(9). 1826–1842. 175 indexed citations

Soong, Bing‐Wen, Yen‐Hua Huang, Pei‐Chien Tsai, et al.. (2013). Exome Sequencing Identifies GNB4 Mutations as a Cause of Dominant Intermediate Charcot-Marie-Tooth Disease. The American Journal of Human Genetics. 92(3). 422–430. 37 indexed citations

Lin, Kuen‐Tyng, Shu‐Chuan Chen, De-Leung Gu, et al.. (2013). Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma. Hepatology. 58(1). 239–250. 42 indexed citations

Soong, Bing‐Wen, Pang‐Hsien Tu, Kon‐Ping Lin, et al.. (2012). A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan. Neurobiology of Aging. 33(9). 2232.e11–2232.e18. 45 indexed citations

Liu, Zhuo‐Hao, et al.. (2011). Predisposing factors of pituitary hemorrhage. European Journal of Neurology. 19(5). 733–738. 13 indexed citations

Tu, Pang‐Hsien, et al.. (2011). Hyperphosphorylation as a Defense Mechanism to Reduce TDP-43 Aggregation. PLoS ONE. 6(8). e23075–e23075. 94 indexed citations

10.

Wang, Yiwei, Pang‐Hsien Tu, Kuen‐Tyng Lin, et al.. (2011). Identification of Oncogenic Point Mutations and Hyperphosphorylation of Anaplastic Lymphoma Kinase in Lung Cancer. Neoplasia. 13(8). 704–IN24. 39 indexed citations

11.

Chu, Pei-Ming, Shih‐Hwa Chiou, Tsann-Long Su, et al.. (2011). Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response. Radiation Oncology. 6(1). 7–7. 20 indexed citations

12.

Soong, Bing‐Wen, et al.. (2010). FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS. Neurobiology of Aging. 32(3). 553.e13–553.e21. 59 indexed citations

13.

Chen, Li-Hsin, Che-Chuan Loong, Tsann-Long Su, et al.. (2010). Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway. Biochemical Pharmacology. 81(5). 594–605. 44 indexed citations

14.

Chen, Kuei‐Ho, Ryan Yeh‐Yung Lin, Pang‐Hsien Tu, et al.. (2010). Induction of Amyloid Fibrils by the C-Terminal Fragments of TDP-43 in Amyotrophic Lateral Sclerosis. Journal of the American Chemical Society. 132(4). 1186–1187. 120 indexed citations

15.

Chen, Rong‐Long, Ikuyo Ueda, Shinsaku Imashuku, et al.. (2007). Cytophagic histiocytic panniculitis with fatal haemophagocytic lymphohistiocytosis in a paediatric patient with perforin gene mutation. Journal of Clinical Pathology. 60(10). 1168–1169. 13 indexed citations

16.

Hope, Andrew, David B. Mansur, Pang‐Hsien Tu, & Joseph R. Simpson. (2006). Metachronous secondary atypical meningioma and anaplastic astrocytoma after postoperative craniospinal irradiation for medulloblastoma. Child s Nervous System. 22(9). 1201–1207. 21 indexed citations

17.

Forman, Mark S., Ian R. Mackenzie, Nigel J. Cairns, et al.. (2006). Novel Ubiquitin Neuropathology in Frontotemporal Dementia WithValosin-Containing ProteinGene Mutations. Journal of Neuropathology & Experimental Neurology. 65(6). 571–581. 173 indexed citations

18.

Ashley, William W., Prithvi Narayan, Tae Sung Park, et al.. (2005). Incidental pediatric intraparenchymal xanthogranuloma. Journal of Neurosurgery Pediatrics. 102(3). 307–310. 19 indexed citations

19.

Jost, Sarah C., Pang‐Hsien Tu, & Neill M. Wright. (2003). Symptomatic Intraosseous Synovial Cyst in the Cervical Spine: A Case Report. Spine. 28(17). E344–E346. 27 indexed citations

20.

Tu, Pang‐Hsien, James E. Galvin, Minami Baba, et al.. (1998). Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein. Annals of Neurology. 44(3). 415–422. 558 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact